Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
暂无分享，去创建一个
W. Hagopian | S. Pillemer | S. Aronoff | B. Bode | K. Herold | S. Koenig | J. Ludvigsson | N. Sherry | E. Bonvini | R. Wilder | R. Ferry | K. Stein | A. Daifotis | D. Carlin | K. King | S. Johnson | S. Jain | Jack Wahlen | Christopher Holland